{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:12:13Z","timestamp":1791562333467,"version":"4.3.4"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Warburg effect in tumour cells is associated with the upregulation of glycolysis to generate ATP, even under normoxic conditions and the presence of fully functioning mitochondria. However, scientific advances made over the past 15 years have reformed this perspective, demonstrating the importance of oxidative phosphorylation (OXPHOS) as well as glycolysis in malignant cells. The metabolic phenotypes in melanoma display heterogeneic dynamism (metabolic plasticity) between glycolysis and OXPHOS, conferring a survival advantage to adapt to harsh conditions and pathways of chemoresistance. Furthermore, the simultaneous upregulation of both OXPHOS and glycolysis (metabolic symbiosis) has been shown to be vital for melanoma progression. The tumour microenvironment (TME) has an essential supporting role in promoting progression, invasion and metastasis of melanoma. Mesenchymal stromal cells (MSCs) in the TME show a symbiotic relationship with melanoma, protecting tumour cells from apoptosis and conferring chemoresistance. With the significant role of OXPHOS in metabolic plasticity and symbiosis, our review outlines how mitochondrial transfer from MSCs to melanoma tumour cells plays a key role in melanoma progression and is the mechanism by which melanoma cells regain OXPHOS capacity even in the presence of mitochondrial mutations. The studies outlined in this review indicate that targeting mitochondrial trafficking is a potential novel therapeutic approach for this highly refractory disease.<\/jats:p>","DOI":"10.1038\/s41416-020-01159-y","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T23:19:42Z","timestamp":1605655182000},"page":"115-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Mitochondrial oxidative phosphorylation in cutaneous melanoma"],"prefix":"10.1038","volume":"124","author":[{"given":"Prakrit R.","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian M.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Rushworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Moncrieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"1159_CR1","doi-asserted-by":"crossref","unstructured":"Laikova, K. V., Oberemok, V. V., Krasnodubets, A. M., Gal\u2019chinsky, N. V., Useinov, R. Z., Novikov, I. A., et al. Advances in the understanding of skin cancer: ultraviolet radiation, mutations, and antisense oligonucleotides as anticancer drugs. Molecules 24, 1516 (2019).","DOI":"10.3390\/molecules24081516"},{"key":"1159_CR2","first-page":"228","volume":"6","author":"Y Liu","year":"2014","unstructured":"Liu, Y. & Sheikh, M. S. Melanoma: molecular pathogenesis and therapeutic management. Mol. Cell Pharmacol. 6, 228 (2014).","journal-title":"Mol. Cell Pharmacol."},{"key":"1159_CR3","unstructured":"UK CR. Melanoma skin cancer statistics. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/melanoma-skin-cancer (2019)."},{"key":"1159_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman, R. I. & Lin, J. Y. Cutaneous melanoma\u2014a review in detection, staging, and management. Hematol. Oncol. Clin. North Am. 33, 25\u201338 (2019).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"1159_CR5","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J., Marquez, N., Dolgert, A., Fukutaki, K., Fullman, N., McGaughey, M. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"1159_CR6","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","volume":"20","author":"LE Davis","year":"2019","unstructured":"Davis, L. E., Shalin, S. C. & Tackett, A. J. Current state of melanoma diagnosis and treatment. Cancer Biol. Ther. 20, 1366\u20131379 (2019).","journal-title":"Cancer Biol. Ther."},{"key":"1159_CR7","first-page":"CD001215","volume":"2","author":"T Crosby","year":"2018","unstructured":"Crosby, T., Fish, R., Coles, B. & Mason, M. WITHDRAWN: systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst. Rev. 2, CD001215 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1159_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00228-018-2590-6","volume":"75","author":"M Polkowska","year":"2019","unstructured":"Polkowska, M., Ekk-Cierniakowski, P., Czepielewska, E. & Kozlowska-Wojciechowska, M. Efficacy and safety of BRAF inhibitors and anti-CTLA4 antibody in melanoma patients-real-world data. Eur. J. Clin. Pharmacol. 75, 329\u2013334 (2019).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/OTT.S39096","volume":"8","author":"F Spagnolo","year":"2015","unstructured":"Spagnolo, F., Ghiorzo, P., Orgiano, L., Pastorino, L., Picasso, V., Tornari, E. et al. BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. Onco Targets Ther. 8, 157\u2013168 (2015).","journal-title":"Onco Targets Ther."},{"key":"1159_CR10","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.7150\/jca.44413","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang, P., Zhang, X., Sun, N., Zhao, Z. & He, J. Comprehensive analysis of the tumor microenvironment in cutaneous melanoma associated with immune infiltration. J. Cancer 11, 3858\u20133870 (2020).","journal-title":"J. Cancer"},{"key":"1159_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-02189-8","volume":"18","author":"B Cacho-Diaz","year":"2020","unstructured":"Cacho-Diaz, B., Garcia-Botello, D. R., Wegman-Ostrosky, T., Reyes-Soto, G., Ortiz-Sanchez, E. & Herrera-Montalvo, L. A. Tumor microenvironment differences between primary tumor and brain metastases. J. Transl. Med. 18, 1 (2020).","journal-title":"J. Transl. Med."},{"key":"1159_CR12","first-page":"5399","volume":"15","author":"M Pieniazek","year":"2018","unstructured":"Pieniazek, M., Matkowski, R. & Donizy, P. Macrophages in skin melanoma-the key element in melanomagenesis. Oncol. Lett. 15, 5399\u20135404 (2018).","journal-title":"Oncol. Lett."},{"key":"1159_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/PAT.0b013e328363b3bd","volume":"45","author":"JM Brandner","year":"2013","unstructured":"Brandner, J. M. & Haass, N. K. Melanoma\u2019s connections to the tumour microenvironment. Pathology 45, 443\u2013452 (2013).","journal-title":"Pathology"},{"key":"1159_CR14","doi-asserted-by":"crossref","unstructured":"Chitty, J. L., Filipe, E. C., Lucas, M. C., Herrmann, D., Cox, T. R. & Timpson, P. Recent advances in understanding the complexities of metastasis. F1000Res 7, F1000 Faculty Rev-1169 (2018).","DOI":"10.12688\/f1000research.15064.1"},{"key":"1159_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1101\/gad.290940.116","volume":"31","author":"P Falletta","year":"2017","unstructured":"Falletta, P., Sanchez-Del-Campo, L., Chauhan, J., Effern, M., Kenyon, A., Kershaw, C. J. et al. Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma. Genes Dev. 31, 18\u201333 (2017).","journal-title":"Genes Dev."},{"key":"1159_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14343","volume":"8","author":"IS Kim","year":"2017","unstructured":"Kim, I. S., Heilmann, S., Kansler, E. R., Zhang, Y., Zimmer, M., Ratnakumar, K. et al. Microenvironment-derived factors driving metastatic plasticity in melanoma. Nat. Commun. 8, 14343 (2017).","journal-title":"Nat. Commun."},{"key":"1159_CR17","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1089\/hum.2010.173","volume":"21","author":"A Augello","year":"2010","unstructured":"Augello, A., De & Bari, C. The regulation of differentiation in mesenchymal stem cells. Hum. Gene Ther. 21, 1226\u20131238 (2010).","journal-title":"Hum. Gene Ther."},{"key":"1159_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","volume":"13","author":"A Keating","year":"2006","unstructured":"Keating, A. Mesenchymal stromal cells. Curr. Opin. Hematol. 13, 419\u2013425 (2006).","journal-title":"Curr. Opin. Hematol."},{"key":"1159_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.actbio.2010.07.037","volume":"7","author":"C Vater","year":"2011","unstructured":"Vater, C., Kasten, P. & Stiehler, M. Culture media for the differentiation of mesenchymal stromal cells. Acta Biomater. 7, 463\u2013477 (2011).","journal-title":"Acta Biomater."},{"key":"1159_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000290897","volume":"37","author":"U Lindner","year":"2010","unstructured":"Lindner, U., Kramer, J., Rohwedel, J. & Schlenke, P. Mesenchymal stem or stromal cells: toward a better understanding of their biology? Transfus. Med. Hemother. 37, 75\u201383 (2010).","journal-title":"Transfus. Med. Hemother."},{"key":"1159_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.20892\/j.issn.2095-3941.2016.0033","volume":"14","author":"AH Nwabo Kamdje","year":"2017","unstructured":"Nwabo Kamdje, A. H., Kamga, P. T., Simo, R. T., Vecchio, L., Seke Etet, P. F., Muller, J. M. et al. Mesenchymal stromal cells\u2019 role in tumor microenvironment: involvement of signaling pathways. Cancer Biol. Med. 14, 129\u2013141 (2017).","journal-title":"Cancer Biol. Med."},{"key":"1159_CR22","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/stem.81","volume":"27","author":"H Wang","year":"2009","unstructured":"Wang, H., Cao, F., De, A., Cao, Y., Contag, C., Gambhir, S. S. et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 27, 1548\u20131558 (2009).","journal-title":"Stem Cells"},{"key":"1159_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2174\/0929867323666151217122033","volume":"23","author":"H Mirzaei","year":"2016","unstructured":"Mirzaei, H., Sahebkar, A., Avan, A., Jaafari, M. R., Salehi, R., Salehi, H. et al. Application of mesenchymal stem cells in melanoma: a potential therapeutic strategy for delivery of targeted agents. Curr. Med. Chem. 23, 455\u2013463 (2016).","journal-title":"Curr. Med. Chem."},{"key":"1159_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fphar.2018.00259","volume":"9","author":"DS Chulpanova","year":"2018","unstructured":"Chulpanova, D. S., Kitaeva, K. V., Tazetdinova, L. G., James, V., Rizvanov, A. A. & Solovyeva, V. V. Application of mesenchymal stem cells for therapeutic agent delivery in anti-tumor treatment. Front. Pharmacol. 9, 259 (2018).","journal-title":"Front. Pharmacol."},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/stem.645","volume":"29","author":"MR Reagan","year":"2011","unstructured":"Reagan, M. R. & Kaplan, D. L. Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 29, 920\u2013927 (2011).","journal-title":"Stem Cells"},{"key":"1159_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0597-8","volume":"16","author":"SM Ridge","year":"2017","unstructured":"Ridge, S. M., Sullivan, F. J. & Glynn, S. A. Mesenchymal stem cells: key players in cancer progression. Mol. Cancer 16, 31 (2017).","journal-title":"Mol. Cancer"},{"key":"1159_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2119\/molmed.2010.00157","volume":"17","author":"K Suzuki","year":"2011","unstructured":"Suzuki, K., Sun, R., Origuchi, M., Kanehira, M., Takahata, T., Itoh, J. et al. Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol. Med. 17, 579\u2013587 (2011).","journal-title":"Mol. Med."},{"key":"1159_CR28","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.3892\/ol.2016.4523","volume":"11","author":"A Vartanian","year":"2016","unstructured":"Vartanian, A., Karshieva, S., Dombrovsky, V. & Belyavsky, A. Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry. Oncol. Lett. 11, 4264\u20134268 (2016).","journal-title":"Oncol. Lett."},{"key":"1159_CR29","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/01.tp.0000236098.13804.0b","volume":"82","author":"F Djouad","year":"2006","unstructured":"Djouad, F., Bony, C., Apparailly, F., Louis-Plence, P., Jorgensen, C. & Noel, D. Earlier onset of syngeneic tumors in the presence of mesenchymal stem cells. Transplantation 82, 1060\u20131066 (2006).","journal-title":"Transplantation"},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F Djouad","year":"2003","unstructured":"Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J. et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102, 3837\u20133844 (2003).","journal-title":"Blood"},{"key":"1159_CR31","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1111\/j.1582-4934.2010.01215.x","volume":"15","author":"Z Han","year":"2011","unstructured":"Han, Z., Tian, Z., Lv, G., Zhang, L., Jiang, G., Sun, K. et al. Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J. Cell Mol. Med. 15, 2343\u20132352 (2011).","journal-title":"J. Cell Mol. Med."},{"key":"1159_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-129","volume":"9","author":"L Kucerova","year":"2010","unstructured":"Kucerova, L., Matuskova, M., Hlubinova, K., Altanerova, V. & Altaner, C. Tumor cell behaviour modulation by mesenchymal stromal cells. Mol. Cancer 9, 129 (2010).","journal-title":"Mol. Cancer"},{"key":"1159_CR33","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nm.2753","volume":"18","author":"H Peinado","year":"2012","unstructured":"Peinado, H., Aleckovic, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883\u2013891 (2012).","journal-title":"Nat. Med."},{"key":"1159_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12307-014-0151-9","volume":"8","author":"L Kucerova","year":"2015","unstructured":"Kucerova, L., Zmajkovic, J., Toro, L., Skolekova, S., Demkova, L. & Matuskova, M. Tumor-driven molecular changes in human mesenchymal stromal cells. Cancer Microenviron. 8, 1\u201314 (2015).","journal-title":"Cancer Microenviron."},{"key":"1159_CR35","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/gt.2014.66","volume":"21","author":"L Kucerova","year":"2014","unstructured":"Kucerova, L., Skolekova, S., Demkova, L., Bohovic, R. & Matuskova, M. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC\/5FC therapy in human melanoma xenograft model. Gene Ther. 21, 874\u2013887 (2014).","journal-title":"Gene Ther."},{"key":"1159_CR36","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1158\/0008-5472.CAN-13-1656","volume":"74","author":"W Ling","year":"2014","unstructured":"Ling, W., Zhang, J., Yuan, Z., Ren, G., Zhang, L., Chen, X. et al. Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res. 74, 1576\u20131587 (2014).","journal-title":"Cancer Res."},{"key":"1159_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3389\/fonc.2020.00722","volume":"10","author":"A Avagliano","year":"2020","unstructured":"Avagliano, A., Fiume, G., Pelagalli, A., Sanita, G., Ruocco, M. R., Montagnani, S. et al. Metabolic plasticity of melanoma cells and their crosstalk with tumor microenvironment. Front. Oncol. 10, 722 (2020).","journal-title":"Front. Oncol."},{"key":"1159_CR38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/pcmr.12661","volume":"31","author":"GM Fischer","year":"2018","unstructured":"Fischer, G. M., Vashisht Gopal, Y. N., McQuade, J. L., Peng, W., DeBerardinis, R. J. & Davies, M. A. Metabolic strategies of melanoma cells: mechanisms, interactions with the tumor microenvironment, and therapeutic implications. Pigment Cell Melanoma Res. 31, 11\u201330 (2018).","journal-title":"Pigment Cell Melanoma Res."},{"key":"1159_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tcb.2017.06.003","volume":"27","author":"CA Lyssiotis","year":"2017","unstructured":"Lyssiotis, C. A. & Kimmelman, A. C. Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 27, 863\u2013875 (2017).","journal-title":"Trends Cell Biol."},{"key":"1159_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","volume":"1807","author":"C Jose","year":"2011","unstructured":"Jose, C., Bellance, N. & Rossignol, R. Choosing between glycolysis and oxidative phosphorylation: a tumor\u2019s dilemma? Biochim. Biophys. Acta 1807, 552\u2013561 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"1159_CR41","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1016\/j.biocel.2009.08.012","volume":"41","author":"N Bellance","year":"2009","unstructured":"Bellance, N., Benard, G., Furt, F., Begueret, H., Smolkova, K., Passerieux, E. et al. Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int. J. Biochem. Cell Biol. 41, 2566\u20132577 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1159_CR42","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519\u2013530 (1927).","journal-title":"J. Gen. Physiol."},{"key":"1159_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.molmed.2014.12.007","volume":"21","author":"C Abildgaard","year":"2015","unstructured":"Abildgaard, C. & Guldberg, P. Molecular drivers of cellular metabolic reprogramming in melanoma. Trends Mol. Med. 21, 164\u2013171 (2015).","journal-title":"Trends Mol. Med."},{"key":"1159_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.18632\/oncotarget.965","volume":"4","author":"A Hall","year":"2013","unstructured":"Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C. et al. Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene. Oncotarget 4, 584\u2013599 (2013).","journal-title":"Oncotarget"},{"key":"1159_CR45","doi-asserted-by":"publisher","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","volume":"286","author":"DA Scott","year":"2011","unstructured":"Scott, D. A., Richardson, A. D., Filipp, F. V., Knutzen, C. A., Chiang, G. G., Ronai, Z. A. et al. Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect. J. Biol. Chem. 286, 42626\u201342634 (2011).","journal-title":"J. Biol. Chem."},{"key":"1159_CR46","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ol.2012.928","volume":"4","author":"J Zheng","year":"2012","unstructured":"Zheng, J. Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol. Lett. 4, 1151\u20131157 (2012).","journal-title":"Oncol. Lett."},{"key":"1159_CR47","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1080\/17460441.2016.1201057","volume":"11","author":"A Kim","year":"2016","unstructured":"Kim, A. & Cohen, M. S. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma. Expert Opin. Drug Discov. 11, 907\u2013916 (2016).","journal-title":"Expert Opin. Drug Discov."},{"key":"1159_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949\u2013954 (2002).","journal-title":"Nature"},{"key":"1159_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-85","volume":"10","author":"PA Ascierto","year":"2012","unstructured":"Ascierto, P. A., Kirkwood, J. M., Grob, J. J., Simeone, E., Grimaldi, A. M., Maio, M. et al. The role of BRAF V600 mutation in melanoma. J. Transl. Med. 10, 85 (2012).","journal-title":"J. Transl. Med."},{"key":"1159_CR50","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.bbabio.2017.01.013","volume":"1858","author":"M Hosseini","year":"2017","unstructured":"Hosseini, M., Kasraian, Z. & Rezvani, H. R. Energy metabolism in skin cancers: a therapeutic perspective. Biochim. Biophys. Acta Bioenerg. 1858, 712\u2013722 (2017).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"1159_CR51","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","volume":"23","author":"R Haq","year":"2013","unstructured":"Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G. C. et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 23, 302\u2013315 (2013).","journal-title":"Cancer Cell"},{"key":"1159_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","volume":"23","author":"F Vazquez","year":"2013","unstructured":"Vazquez, F., Lim, J. H., Chim, H., Bhalla, K., Girnun, G., Pierce, K. et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287\u2013301 (2013).","journal-title":"Cancer Cell"},{"key":"1159_CR53","first-page":"105","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk, A. & Polyak, K. Tumor heterogeneity: causes and consequences. Biochim. Biophys. Acta 1805, 105\u2013117 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"1159_CR54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccr.2012.08.014","volume":"22","author":"P Caro","year":"2012","unstructured":"Caro, P., Kishan, A. U., Norberg, E., Stanley, I. A., Chapuy, B., Ficarro, S. B. et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 22, 547\u2013560 (2012).","journal-title":"Cancer Cell"},{"key":"1159_CR55","first-page":"198","volume":"9","author":"F Bost","year":"2019","unstructured":"Bost, F. & Kaminski, L. The metabolic modulator PGC-1alpha in cancer. Am. J. Cancer Res. 9, 198\u2013211 (2019).","journal-title":"Am. J. Cancer Res."},{"key":"1159_CR56","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/ncb3039","volume":"16","author":"VS LeBleu","year":"2014","unstructured":"LeBleu, V. S., O\u2019Connell, J. T., Gonzalez Herrera, K. N., Wikman, H., Pantel, K., Haigis, M. C. et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16, 992\u20131003 (2014).","journal-title":"Nat. Cell Biol."},{"key":"1159_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-11-76","volume":"11","author":"J Ho","year":"2012","unstructured":"Ho, J., de Moura, M. B., Lin, Y., Vincent, G., Thorne, S., Duncan, L. M. et al. Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol. Cancer 11, 76 (2012).","journal-title":"Mol. Cancer"},{"key":"1159_CR58","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3109\/0284186X.2015.1043026","volume":"54","author":"F Petrelli","year":"2015","unstructured":"Petrelli, F., Cabiddu, M., Coinu, A., Borgonovo, K., Ghilardi, M., Lonati, V. et al. Prognostic role of lactate dehydrogenase in solid tumors: a systematic review and meta-analysis of 76 studies. Acta Oncol. 54, 961\u2013970 (2015).","journal-title":"Acta Oncol."},{"key":"1159_CR59","unstructured":"Farhana, A., Lappin, S. L. Biochemistry, Lactate Dehydrogenase (LDH) (StatPearls, Treasure Island, 2020)."},{"key":"1159_CR60","doi-asserted-by":"publisher","first-page":"e40690","DOI":"10.1371\/journal.pone.0040690","volume":"7","author":"M Barbi de Moura","year":"2012","unstructured":"Barbi de Moura, M., Vincent, G., Fayewicz, S. L., Bateman, N. W., Hood, B. L., Sun, M. et al. Mitochondrial respiration-an important therapeutic target in melanoma. PLoS ONE 7, e40690 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR61","doi-asserted-by":"publisher","first-page":"e30750","DOI":"10.1371\/journal.pone.0030750","volume":"7","author":"K Xu","year":"2012","unstructured":"Xu, K., Mao, X., Mehta, M., Cui, J., Zhang, C. & Xu, Y. A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers. PLoS ONE 7, e30750 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR62","doi-asserted-by":"crossref","unstructured":"Jia, D., Park, J. H., Jung, K. H., Levine, H., Kaipparettu, B. A. Elucidating the metabolic plasticity of cancer: mitochondrial reprogramming and hybrid metabolic states. Cells 7, 21 (2018).","DOI":"10.3390\/cells7030021"},{"key":"1159_CR63","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1074\/jbc.M117.786442","volume":"292","author":"AP Trotta","year":"2017","unstructured":"Trotta, A. P., Gelles, J. D., Serasinghe, M. N., Loi, P., Arbiser, J. L. & Chipuk, J. E. Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition. J. Biol. Chem. 292, 11727\u201311739 (2017).","journal-title":"J. Biol. Chem."},{"key":"1159_CR64","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1158\/0008-5472.CAN-14-1392","volume":"74","author":"YN Gopal","year":"2014","unstructured":"Gopal, Y. N., Rizos, H., Chen, G., Deng, W., Frederick, D. T., Cooper, Z. A. et al. Inhibition of mTORC1\/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1alpha and oxidative phosphorylation in melanoma. Cancer Res. 74, 7037\u20137047 (2014).","journal-title":"Cancer Res"},{"key":"1159_CR65","doi-asserted-by":"publisher","first-page":"36945","DOI":"10.18632\/oncotarget.26421","volume":"9","author":"JL Figarola","year":"2018","unstructured":"Figarola, J. L., Singhal, J., Singhal, S., Kusari, J. & Riggs, A. Bioenergetic modulation with the mitochondria uncouplers SR4 and niclosamide prevents proliferation and growth of treatment-naive and vemurafenib-resistant melanomas. Oncotarget 9, 36945\u201336965 (2018).","journal-title":"Oncotarget"},{"key":"1159_CR66","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2019.07.016","volume":"59","author":"MR Ruocco","year":"2019","unstructured":"Ruocco, M. R., Avagliano, A., Granato, G., Vigliar, E., Masone, S., Montagnani, S. et al. Metabolic flexibility in melanoma: a potential therapeutic target. Semin. Cancer Biol. 59, 187\u2013207 (2019).","journal-title":"Semin. Cancer Biol."},{"key":"1159_CR67","doi-asserted-by":"publisher","first-page":"39473","DOI":"10.18632\/oncotarget.7790","volume":"7","author":"P Corazao-Rozas","year":"2016","unstructured":"Corazao-Rozas, P., Guerreschi, P., Andre, F., Gabert, P. E., Lancel, S., Dekiouk, S. et al. Mitochondrial oxidative phosphorylation controls cancer cell\u2019s life and death decisions upon exposure to MAPK inhibitors. Oncotarget 7, 39473\u201339485 (2016).","journal-title":"Oncotarget"},{"key":"1159_CR68","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.semcdb.2019.05.001","volume":"98","author":"V Audrito","year":"2020","unstructured":"Audrito, V., Manago, A., Gaudino, F. & Deaglio, S. Targeting metabolic reprogramming in metastatic melanoma: the key role of nicotinamide phosphoribosyltransferase (NAMPT). Semin. Cell Dev. Biol. 98, 192\u2013201 (2020).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1159_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1042\/bj3500219","volume":"350","author":"KS Dimmer","year":"2000","unstructured":"Dimmer, K. S., Friedrich, B., Lang, F., Deitmer, J. W. & Broer, S. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem. J. 350, 219\u2013227 (2000).","journal-title":"Biochem. J."},{"key":"1159_CR70","doi-asserted-by":"publisher","first-page":"9030","DOI":"10.1074\/jbc.M511397200","volume":"281","author":"MS Ullah","year":"2006","unstructured":"Ullah, M. S., Davies, A. J. & Halestrap, A. P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J. Biol. Chem. 281, 9030\u20139037 (2006).","journal-title":"J. Biol. Chem."},{"key":"1159_CR71","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fonc.2020.00005","volume":"10","author":"L Ma","year":"2020","unstructured":"Ma, L. & Zong, X. Metabolic symbiosis in chemoresistance: refocusing the role of aerobic glycolysis. Front. Oncol. 10, 5 (2020).","journal-title":"Front. Oncol."},{"key":"1159_CR72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/cr.2017.155","volume":"28","author":"PE Porporato","year":"2018","unstructured":"Porporato, P. E., Filigheddu, N., Pedro, J. M. B., Kroemer, G. & Galluzzi, L. Mitochondrial metabolism and cancer. Cell Res. 28, 265\u2013280 (2018).","journal-title":"Cell Res"},{"key":"1159_CR73","doi-asserted-by":"publisher","first-page":"185","DOI":"10.18632\/aging.100134","volume":"2","author":"S Pavlides","year":"2010","unstructured":"Pavlides, S., Tsirigos, A., Vera, I., Flomenberg, N., Frank, P. G., Casimiro, M. C. et al. Transcriptional evidence for the \u201cReverse Warburg Effect\u201d in human breast cancer tumor stroma and metastasis: similarities with oxidative stress, inflammation, Alzheimer\u2019s disease, and \u201cNeuron-Glia Metabolic Coupling\u201d. Aging (Albany NY) 2, 185\u2013199 (2010).","journal-title":"Aging (Albany NY)"},{"key":"1159_CR74","first-page":"926729","volume":"2014","author":"CD Gonzalez","year":"2014","unstructured":"Gonzalez, C. D., Alvarez, S., Ropolo, A., Rosenzvit, C., Bagnes, M. F. & Vaccaro, M. I. Autophagy, Warburg, and Warburg reverse effects in human cancer. Biomed. Res. Int. 2014, 926729 (2014).","journal-title":"Biomed. Res. Int"},{"key":"1159_CR75","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"TM Ashton","year":"2018","unstructured":"Ashton, T. M., McKenna, W. G., Kunz-Schughart, L. A. & Higgins, G. S. Oxidative phosphorylation as an emerging target in cancer therapy. Clin. Cancer Res. 24, 2482\u20132490 (2018).","journal-title":"Clin. Cancer Res."},{"key":"1159_CR76","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng.f.94","volume":"40","author":"KJ Krishnan","year":"2008","unstructured":"Krishnan, K. J., Reeve, A. K., Samuels, D. C., Chinnery, P. F., Blackwood, J. K., Taylor, R. W. et al. What causes mitochondrial DNA deletions in human cells? Nat. Genet. 40, 275\u2013279 (2008).","journal-title":"Nat. Genet."},{"key":"1159_CR77","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/rej.2009.0948","volume":"13","author":"MV Berridge","year":"2010","unstructured":"Berridge, M. V. & Tan, A. S. Effects of mitochondrial gene deletion on tumorigenicity of metastatic melanoma: reassessing the Warburg effect. Rejuvenation Res. 13, 139\u2013141 (2010).","journal-title":"Rejuvenation Res."},{"key":"1159_CR78","first-page":"994","volume":"33","author":"T Ahmad","year":"2014","unstructured":"Ahmad, T., Mukherjee, S., Pattnaik, B., Kumar, M., Singh, S., Kumar, M. et al. Miro1 regulates intercellular mitochondrial transport & enhances mesenchymal stem cell rescue efficacy. EMBO J. 33, 994\u20131010 (2014).","journal-title":"EMBO J."},{"key":"1159_CR79","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1182\/blood.2019001398","volume":"134","author":"R Burt","year":"2019","unstructured":"Burt, R., Dey, A., Aref, S., Aguiar, M., Akarca, A., Bailey, K. et al. Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress. Blood 134, 1415\u20131429 (2019).","journal-title":"Blood"},{"key":"1159_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/srep09073","volume":"5","author":"A Caicedo","year":"2015","unstructured":"Caicedo, A., Fritz, V., Brondello, J. M., Ayala, M., Dennemont, I., Abdellaoui, N. et al. MitoCeption as a new tool to assess the effects of mesenchymal stem\/stromal cell mitochondria on cancer cell metabolism and function. Sci. Rep. 5, 9073 (2015).","journal-title":"Sci. Rep."},{"key":"1159_CR81","doi-asserted-by":"publisher","first-page":"e32778","DOI":"10.1371\/journal.pone.0032778","volume":"7","author":"YM Cho","year":"2012","unstructured":"Cho, Y. M., Kim, J. H., Kim, M., Park, S. J., Koh, S. H., Ahn, H. S. et al. Mesenchymal stem cells transfer mitochondria to the cells with virtually no mitochondrial function but not with pathogenic mtDNA mutations. PLoS ONE 7, e32778 (2012).","journal-title":"PLoS ONE"},{"key":"1159_CR82","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mito.2015.02.006","volume":"22","author":"HY Lin","year":"2015","unstructured":"Lin, H. Y., Liou, C. W., Chen, S. D., Hsu, T. Y., Chuang, J. H., Wang, P. W. et al. Mitochondrial transfer from Wharton\u2019s jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function. Mitochondrion 22, 31\u201344 (2015).","journal-title":"Mitochondrion"},{"key":"1159_CR83","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","volume":"79","author":"CR Marlein","year":"2019","unstructured":"Marlein, C. R., Piddock, R. E., Mistry, J. J., Zaitseva, L., Hellmich, C., Horton, R. H. et al. CD38-driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma. Cancer Res. 79, 2285\u20132297 (2019).","journal-title":"Cancer Res."},{"key":"1159_CR84","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1182\/blood-2017-03-772939","volume":"130","author":"CR Marlein","year":"2017","unstructured":"Marlein, C. R., Zaitseva, L., Piddock, R. E., Robinson, S. D., Edwards, D. R., Shafat, M. S. et al. NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts. Blood 130, 1649\u20131660 (2017).","journal-title":"Blood"},{"key":"1159_CR85","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood-2015-07-655860","volume":"128","author":"R Moschoi","year":"2016","unstructured":"Moschoi, R., Imbert, V., Nebout, M., Chiche, J., Mary, D., Prebet, T. et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood 128, 253\u2013264 (2016).","journal-title":"Blood"},{"key":"1159_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-94","volume":"11","author":"J Pasquier","year":"2013","unstructured":"Pasquier, J., Guerrouahen, B. S., Al Thawadi, H., Ghiabi, P., Maleki, M., Abu-Kaoud, N. et al. Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance. J. Transl. Med. 11, 94 (2013).","journal-title":"J. Transl. Med"},{"key":"1159_CR87","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees, J. L., Olson, S. D., Whitney, M. J. & Prockop, D. J. Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl Acad. Sci. USA 103, 1283\u20131288 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR88","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cmet.2014.12.003","volume":"21","author":"AS Tan","year":"2015","unstructured":"Tan, A. S., Baty, J. W., Dong, L. F., Bezawork-Geleta, A., Endaya, B., Goodwin, J. et al. Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA. Cell Metab. 21, 81\u201394 (2015).","journal-title":"Cell Metab."},{"key":"1159_CR89","unstructured":"Mistry, J. J., Moore, J. A., Kumar, P., Marlein, C. R., Hellmich, C., Pillinger, G., et al. Daratumumab inhibits acute myeloid leukaemia metabolic capacity by blocking mitochondrial transfer from mesenchymal stromal cells. Haematologica https:\/\/haematologica.org\/article\/view\/9692 (2020)."},{"key":"1159_CR90","doi-asserted-by":"crossref","unstructured":"Dong, L. F., Kovarova, J., Bajzikova, M., Bezawork-Geleta, A., Svec, D., Endaya, B., et al. Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells. elife 6, e22187 (2017).","DOI":"10.7554\/eLife.22187"},{"key":"1159_CR91","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature12985","volume":"505","author":"JR Friedman","year":"2014","unstructured":"Friedman, J. R. & Nunnari, J. Mitochondrial form and function. Nature 505, 335\u2013343 (2014).","journal-title":"Nature"},{"key":"1159_CR92","doi-asserted-by":"publisher","first-page":"407536","DOI":"10.4061\/2011\/407536","volume":"2011","author":"C Desler","year":"2011","unstructured":"Desler, C., Marcker, M. L., Singh, K. K. & Rasmussen, L. J. The importance of mitochondrial DNA in aging and cancer. J. Aging Res. 2011, 407536 (2011).","journal-title":"J. Aging Res."},{"key":"1159_CR93","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fcell.2016.00107","volume":"4","author":"D Torralba","year":"2016","unstructured":"Torralba, D., Baixauli, F. & Sanchez-Madrid, F. Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer. Front. Cell Dev. Biol. 4, 107 (2016).","journal-title":"Front. Cell Dev. Biol."},{"key":"1159_CR94","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/stem.2922","volume":"37","author":"LMA Murray","year":"2019","unstructured":"Murray, L. M. A. & Krasnodembskaya, A. D. Concise review: intercellular communication via organelle transfer in the biology and therapeutic applications of stem cells. Stem Cells 37, 14\u201325 (2019).","journal-title":"Stem Cells"},{"key":"1159_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13287-016-0354-8","volume":"7","author":"KA Sinclair","year":"2016","unstructured":"Sinclair, K. A., Yerkovich, S. T., Hopkins, P. M. & Chambers, D. C. Characterization of intercellular communication and mitochondrial donation by mesenchymal stromal cells derived from the human lung. Stem Cell Res. Ther. 7, 91 (2016).","journal-title":"Stem Cell Res. Ther."},{"key":"1159_CR96","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.febslet.2009.03.065","volume":"583","author":"NV Bukoreshtliev","year":"2009","unstructured":"Bukoreshtliev, N. V., Wang, X., Hodneland, E., Gurke, S., Barroso, J. F. & Gerdes, H. H. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Lett. 583, 1481\u20131488 (2009).","journal-title":"FEBS Lett."},{"key":"1159_CR97","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.1093133","volume":"303","author":"A Rustom","year":"2004","unstructured":"Rustom, A., Saffrich, R., Markovic, I., Walther, P. & Gerdes, H. H. Nanotubular highways for intercellular organelle transport. Science 303, 1007\u20131010 (2004).","journal-title":"Science"},{"key":"1159_CR98","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1161\/01.RES.0000168650.23479.0c","volume":"96","author":"M Koyanagi","year":"2005","unstructured":"Koyanagi, M., Brandes, R. P., Haendeler, J., Zeiher, A. M. & Dimmeler, S. Cell-to-cell connection of endothelial progenitor cells with cardiac myocytes by nanotubes: a novel mechanism for cell fate changes? Circ. Res. 96, 1039\u20131041 (2005).","journal-title":"Circ. Res."},{"key":"1159_CR99","doi-asserted-by":"publisher","first-page":"29828","DOI":"10.3402\/jev.v5.29828","volume":"5","author":"RC Lai","year":"2016","unstructured":"Lai, R. C., Tan, S. S., Yeo, R. W., Choo, A. B., Reiner, A. T., Su, Y. et al. MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. J. Extracell. Vesicles 5, 29828 (2016).","journal-title":"J. Extracell. Vesicles"},{"key":"1159_CR100","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo, G. & Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373\u2013383 (2013).","journal-title":"J. Cell Biol."},{"key":"1159_CR101","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/jb\/mvj128","volume":"140","author":"G van Niel","year":"2006","unstructured":"van Niel, G., Porto-Carreiro, I., Simoes, S. & Raposo, G. Exosomes: a common pathway for a specialized function. J. Biochem. 140, 13\u201321 (2006).","journal-title":"J. Biochem."},{"key":"1159_CR102","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","volume":"8","author":"C Tricarico","year":"2017","unstructured":"Tricarico, C., Clancy, J. & D\u2019Souza-Schorey, C. Biology and biogenesis of shed microvesicles. Small GTPases 8, 220\u2013232 (2017).","journal-title":"Small GTPases"},{"key":"1159_CR103","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1164\/rccm.201410-1765OC","volume":"192","author":"A Monsel","year":"2015","unstructured":"Monsel, A., Zhu, Y. G., Gennai, S., Hao, Q., Hu, S., Rouby, J. J. et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am. J. Respir. Crit. Care Med. 192, 324\u2013336 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1159_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00702-009-0288-8","volume":"117","author":"M Guescini","year":"2010","unstructured":"Guescini, M., Genedani, S., Stocchi, V. & Agnati, L. F. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J. Neural Transm. (Vienna) 117, 1\u20134 (2010).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"1159_CR105","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.yexcr.2010.04.006","volume":"316","author":"M Guescini","year":"2010","unstructured":"Guescini, M., Guidolin, D., Vallorani, L., Casadei, L., Gioacchini, A. M., Tibollo, P. et al. C2C12 myoblasts release micro-vesicles containing mtDNA and proteins involved in signal transduction. Exp. Cell Res. 316, 1977\u20131984 (2010).","journal-title":"Exp. Cell Res."},{"key":"1159_CR106","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nm.2736","volume":"18","author":"MN Islam","year":"2012","unstructured":"Islam, M. N., Das, S. R., Emin, M. T., Wei, M., Sun, L., Westphalen, K. et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat. Med. 18, 759\u2013765 (2012).","journal-title":"Nat. Med"},{"key":"1159_CR107","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/cib.2.3.8165","volume":"2","author":"EA Eugenin","year":"2009","unstructured":"Eugenin, E. A., Gaskill, P. J. & Berman, J. W. Tunneling nanotubes (TNT): a potential mechanism for intercellular HIV trafficking. Commun. Integr. Biol. 2, 243\u2013244 (2009).","journal-title":"Commun. Integr. Biol."},{"key":"1159_CR108","doi-asserted-by":"publisher","first-page":"24610","DOI":"10.1073\/pnas.1913278116","volume":"116","author":"JJ Mistry","year":"2019","unstructured":"Mistry, J. J., Marlein, C. R., Moore, J. A., Hellmich, C., Wojtowicz, E. E., Smith, J. G. W. et al. ROS-mediated PI3K activation drives mitochondrial transfer from stromal cells to hematopoietic stem cells in response to infection. Proc. Natl Acad. Sci. USA 116, 24610\u201324619 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1159_CR109","first-page":"1960","volume":"6","author":"KI Wada","year":"2017","unstructured":"Wada, K. I., Hosokawa, K., Ito, Y. & Maeda, M. Quantitative control of mitochondria transfer between live single cells using a microfluidic device. Biol. Open 6, 1960\u20131965 (2017).","journal-title":"Biol. Open"},{"key":"1159_CR110","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature08780","volume":"464","author":"Q Zhang","year":"2010","unstructured":"Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W. et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104\u2013107 (2010).","journal-title":"Nature"},{"key":"1159_CR111","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860\u2013867 (2002).","journal-title":"Nature"},{"key":"1159_CR112","unstructured":"Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma | Guidance | NICE [Internet]. Nice.org.uk. https:\/\/www.nice.org.uk\/guidance\/TA573 (2020)."},{"key":"1159_CR113","unstructured":"Daratumumab monotherapy for treating relapsed and refractory multiple myeloma | Guidance | NICE [Internet]. Nice.org.uk. https:\/\/www.nice.org.uk\/guidance\/ta510 (2020)."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01159-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T08:08:33Z","timestamp":1650528513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-01159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":113,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,5]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-01159-y","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No external funding was used in the execution of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}